Dabigatran Etexilate Acid Impurity
Dabigatran Etexilate Acid Impurity is a degradation byproduct arising from the hydrolytic cleavage of the ester linkage in the prodrug Dabigatran Etexilate, yielding a carboxylic acid moiety conjugated to the benzimidazole-tetrahydrofuran scaffold. The compound retains the core pharmacophore of Dabigatran but features an exposed acidic functional group, enhancing its polarity and altering its solubility profile. This impurity is structurally analogous to the active drug but lacks anticoagulant activity due to the absence of the critical ester prodrug functionality. It serves as a reference standard for HPLC-based quantification of process-related impurities in Dabigatran formulations.
On Request
Molecular Formula
N/A
Molecular Weight
N/A
CAS Number
N/A
PubChem CID
N/A
Quick enquiry on WhatsApp:
Ask about this product →
